Add to ORKGremission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myelom
Major improvements have been made in the treatment of myeloma. However, all patients, perhaps with s...
Objective: To investigate post-transplant immunotherapy with escalating donor-lymphocyte infusions (...
This study evaluates the prognostic value of molecular monitoring of minimal residual disease (MRD) ...
Patients in complete clinical remission after myeloablative allogeneic stem cell transplantation (al...
Purpose: To assess the clinical relevance of minimal residual disease (MRD) in patients with multipl...
To describe molecular monitoring of minimal residual disease in patients with myeloma who have achie...
Multiple myeloma (MM) remains as an incurable disease and, although allogeneic hematopoietic stem ce...
Multiple myeloma (MM) remains as an incurable disease and, although allogeneic hematopoietic stem ce...
We identified 103 consecutive patients who, 5 years after allogeneic transplantation for chronic mye...
Allogeneic stem cell transplantation (allo-SCT) has the potential to induce long-term remission in m...
Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remi...
Eighty-six adult patients with inv(16) acute myeloid leukemia (AML) in first complete remission (CR1...
Aims: Recent reports have suggested that extramedullary (EM) relapse of acute myeloid leukemia (AML)...
Allogeneic stem cell transplantation (allo-SCT) has the potential to induce sustained remissions in ...
Development and application of statistical models for medical scientific researc
Major improvements have been made in the treatment of myeloma. However, all patients, perhaps with s...
Objective: To investigate post-transplant immunotherapy with escalating donor-lymphocyte infusions (...
This study evaluates the prognostic value of molecular monitoring of minimal residual disease (MRD) ...
Patients in complete clinical remission after myeloablative allogeneic stem cell transplantation (al...
Purpose: To assess the clinical relevance of minimal residual disease (MRD) in patients with multipl...
To describe molecular monitoring of minimal residual disease in patients with myeloma who have achie...
Multiple myeloma (MM) remains as an incurable disease and, although allogeneic hematopoietic stem ce...
Multiple myeloma (MM) remains as an incurable disease and, although allogeneic hematopoietic stem ce...
We identified 103 consecutive patients who, 5 years after allogeneic transplantation for chronic mye...
Allogeneic stem cell transplantation (allo-SCT) has the potential to induce long-term remission in m...
Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remi...
Eighty-six adult patients with inv(16) acute myeloid leukemia (AML) in first complete remission (CR1...
Aims: Recent reports have suggested that extramedullary (EM) relapse of acute myeloid leukemia (AML)...
Allogeneic stem cell transplantation (allo-SCT) has the potential to induce sustained remissions in ...
Development and application of statistical models for medical scientific researc
Major improvements have been made in the treatment of myeloma. However, all patients, perhaps with s...
Objective: To investigate post-transplant immunotherapy with escalating donor-lymphocyte infusions (...
This study evaluates the prognostic value of molecular monitoring of minimal residual disease (MRD) ...